StockWatch
·

Akums Drugs and Pharmaceuticals Ltd

BSE: 544222

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-41.78122.82287.42452.02Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27

Margin Trend

percentage
OPM %NPM %
0.765.4710.1914.90Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
PeriodQ2 FY27Q1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25
INCOME
Revenue395.05+0.7%392.27+15.9%338.37-8.2%368.61+19.2%309.31-7.0%332.44+1.1%328.75-2.6%337.41
Other Income25.80-1.2%26.10-5.9%27.73-6.3%29.60+9.3%27.08-5.2%28.55-10.9%32.05-5.3%33.84
Total Income420.84+0.6%418.38+14.3%366.10-8.1%398.21+18.4%336.39-6.8%361.00+0.1%360.80-2.8%371.25
EXPENSES
Expenditure377.00+5.0%359.04+5.1%341.60-4.7%358.54+17.5%305.19+1.2%301.49-6.9%323.75+2.3%316.36
Tax11.21-22.7%14.50+119.9%6.59-14.9%7.75+0.2%7.74-47.1%14.64+54.6%9.47-31.0%13.72
PROFIT
PBT43.85-26.1%59.34+172.3%21.79-39.2%35.87+15.0%31.20-47.6%59.51+60.6%37.05-32.5%54.89
Net Profit32.64-27.2%44.84+195.1%15.20-45.9%28.11+19.8%23.46-47.7%44.87+62.6%27.59-33.0%41.17
KEY METRICS
OPM %8.75%-3.61pp12.36%+9.68pp2.68%-2.98pp5.66%+0.20pp5.46%-7.81pp13.27%+7.88pp5.39%+3.00pp2.39%
NPM %7.76%-2.96pp10.72%+6.57pp4.15%-2.91pp7.06%+0.09pp6.97%-5.46pp12.43%+4.78pp7.65%-3.44pp11.09%
EPS2.13-27.3%2.93+196.0%0.99-46.2%1.84+20.3%1.53-47.8%2.93+62.8%1.80-33.1%2.69

Corporate Events

Board MeetingAKUMS
2026
2Nov

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingAKUMS
2026
8Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingAKUMS
2026
23Jul

Board Meeting

The Board Meeting was held on July 23, 2026, to consider and…

BSE Filing ↗
Board MeetingAKUMS
2026
10Jul

Board Meeting

The 22nd Annual General Meeting will be held to receive, con…

BSE Filing ↗
DividendAKUMS
2026
3Jul

₹3 / share

BSE Filing ↗
Board MeetingAKUMS
2024
9Nov

Board Meeting

Consider and approve the Un-audited (Standalone & Consolidat…

BSE Filing ↗
Board MeetingAKUMS
2024
24Aug

Board Meeting

Consider and approve the Un-audited (Standalone & Consolidat…

BSE Filing ↗